Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4761614
Max Phase: Preclinical
Molecular Formula: C47H73F2N9O7
Molecular Weight: 914.15
Molecule Type: Unknown
Associated Items:
ID: ALA4761614
Max Phase: Preclinical
Molecular Formula: C47H73F2N9O7
Molecular Weight: 914.15
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CNC(=O)COCC(=O)NCCCCCCCCCNC(=O)COCC(=O)Nc1ccc([C@H](CCN2[C@@H]3CC[C@H]2C[C@@H](n2c(C)nnc2C(C)C)C3)NC(=O)C2CCC(F)(F)CC2)cc1
Standard InChI: InChI=1S/C47H73F2N9O7/c1-32(2)45-56-55-33(3)58(45)39-26-37-16-17-38(27-39)57(37)25-20-40(54-46(63)35-18-21-47(48,49)22-19-35)34-12-14-36(15-13-34)53-44(62)31-65-30-43(61)52-24-11-9-7-5-6-8-10-23-51-42(60)29-64-28-41(59)50-4/h12-15,32,35,37-40H,5-11,16-31H2,1-4H3,(H,50,59)(H,51,60)(H,52,61)(H,53,62)(H,54,63)/t37-,38+,39+,40-/m0/s1
Standard InChI Key: FSTXIWXRPYKCFE-KQQMQGIYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 914.15 | Molecular Weight (Monoisotopic): 913.5601 | AlogP: 5.63 | #Rotatable Bonds: 27 |
Polar Surface Area: 197.91 | Molecular Species: BASE | HBA: 11 | HBD: 5 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.92 | CX Basic pKa: 9.29 | CX LogP: 2.13 | CX LogD: 0.24 |
Aromatic Rings: 2 | Heavy Atoms: 65 | QED Weighted: 0.07 | Np Likeness Score: -0.91 |
1. Arnatt CK,Falls BA,Yuan Y,Raborg TJ,Masvekar RR,El-Hage N,Selley DE,Nicola AV,Knapp PE,Hauser KF,Zhang Y. (2016) Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization., 24 (22.0): [PMID:27720326] [10.1016/j.bmc.2016.09.059] |
Source(1):